Stockscreener 앱 받기
4.43
1.14%
0.05
Nyxoah Sa 주식(NYXH)의 최신 뉴스
Is Nyxoah SA stock undervalued right nowJuly 2025 Highlights & Weekly Stock Breakout Alerts - mfd.ru
Returns Recap: Will Nyxoah SA benefit from AI trendsWeekly Stock Recap & Community Supported Trade Ideas - baoquankhu1.vn
Is Nyxoah SA stock overvalued or fairly pricedJuly 2025 Update & Fast Gain Swing Trade Alerts - mfd.ru
Can Nyxoah SA expand into new marketsTrade Analysis Summary & Daily Profit Maximizing Trade Tips - mfd.ru
What is the long term forecast for Nyxoah SA stockJuly 2025 Sector Moves & High Accuracy Trade Signal Alerts - mfd.ru
Nyxoah's Revenue On The Rise- Will The Stock Wake From Its Slumber? - RTTNews
Guidance Update: Is now the right time to enter Nyxoah SABond Market & Daily Stock Trend Watchlist - baoquankhu1.vn
Price-Driven Insight from (NYXH) for Rule-Based Strategy - Stock Traders Daily
Aug PreEarnings: Can Nyxoah SA sustain its profitabilityBear Alert & Expert Approved Trade Ideas - baoquankhu1.vn
Price Action: Should I hold or sell Nyxoah SA now2025 Institutional Moves & AI Driven Stock Movement Reports - baoquankhu1.vn
Ideas Watch: Is now the right time to enter Nyxoah SAQuarterly Trade Summary & High Accuracy Investment Entry Signals - baoquankhu1.vn
Will Nyxoah SA benefit from rising consumer demandWeekly Stock Report & Smart Money Movement Tracker - baoquankhu1.vn
Nyxoah (NASDAQ:NYXH) Shares Down 0.4%Time to Sell? - MarketBeat
Nyxoah (NASDAQ:NYXH) Shares Down 0.4% – Time to Sell? - Defense World
Nyxoah Expands Belgian Manufacturing Hub to Support Global Growth in OSA Therapy - TipRanks
Risk Hedge: Is Nyxoah SA stock a good dividend stockTrade Ideas & Long-Term Growth Plans - mfd.ru
Can Nyxoah SA sustain its profitabilityJuly 2025 Big Picture & AI Powered Buy and Sell Recommendations - mfd.ru
Volume Report: Can Nyxoah SA ride the EV waveQuarterly Portfolio Review & Weekly High Return Forecasts - baoquankhu1.vn
Nyxoah Expands Belgian Manufacturing Capacity to Support Global Growth - Sleep Review
Nyxoah SA (NYXH) Investor Outlook: Exploring a 137.85% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Nyxoah invests in further expanding its Belgian manufacturing capacity to support its worldwide growth - marketscreener.com
Nyxoah says co invests expanding its Belgian manufacturing capacity - marketscreener.com
Nyxoah Invests In Further Expanding Its Belgian Manufacturing Capacity To Support Its Worldwide Growth - GlobeNewswire
Does Nyxoah SA have pricing power2025 Risk Factors & Growth Focused Stock Reports - bollywoodhelpline.com
Aug Sectors: Is Flanigans Enterprises Inc stock a falling knife or bargain buy2025 Fundamental Recap & Intraday High Probability Alerts - baoquankhu1.vn
(NYXH) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
NYXH: Rapid U.S. launch and strong clinical results position Genio for significant market growth - TradingView
NYXH: Genio's innovative sleep apnea device drives rapid U.S. adoption and strong early sales - TradingView — Track All Markets
Oppenheimer Maintains Nyxoah SA(NYXH.US) With Buy Rating, Maintains Target Price $13 - 富途牛牛
Nyxoah’s First Full U.S. Sales Quarter Fuels Triple-Digit Revenue Growth in 2025 - TipRanks
Nyxoah (NASDAQ: NYXH) reports preliminary 2025 results and Q1 2026 view - Stock Titan
Stifel reiterates Buy rating on Nyxoah stock, maintains $12 price target By Investing.com - Investing.com South Africa
Stifel Maintains Nyxoah SA(NYXH.US) With Buy Rating, Maintains Target Price $12 - 富途资讯
Stifel reiterates Buy rating on Nyxoah stock, maintains $12 price target - Investing.com Australia
Is Nyxoah SA stock a safe investment in uncertain markets2025 Growth vs Value & Verified Swing Trading Watchlist - Bộ Nội Vụ
Belgium-based Nyxoah’s net revenue expected to increase 348% in Q4 2025 - Medical Buyer
Nyxoah Shares Surge On Strong Q4 Preliminary Revenue - Nasdaq
Nyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2025 and Provides Revenue Guidance for the First Quarter of 2026 - The Manila Times
News - FinancialContent
Publication relating to transparency notification - GlobeNewswire
Nyxoah SA's (EBR:NYXH) market cap rose €19m last week; retail investors who hold 44% profited and so did insiders - simplywall.st
Aug Opening: Is Nyxoah SA stock a contrarian buyJuly 2025 Price Swings & AI Forecasted Entry/Exit Points - Bộ Nội Vụ
Is Nyxoah SA stock a good choice for value investorsSeasonal Picks & what to check before ordering - Улправда
Is Nyxoah SA stock a contrarian buyMarket Risk Summary & Free Fast Gain Swing Trade Alerts - Улправда
How Nyxoah SA (5YI) stock benefits from digital adoptionPortfolio Growth Summary & Free Safe Entry Trade Signal Reports - ulpravda.ru
Aug Intraday: Is Nyxoah SA stock a good choice for value investors2025 Technical Overview & Community Consensus Trade Alerts - Улправда
Why Nyxoah SA stock is recommended by analysts2025 Pullback Review & Safe Entry Momentum Stock Tips - ulpravda.ru
Nyxoah SA (NYXH) Stock Analysis: Exploring a Potential 125.84% Upside in the Healthcare Sector - DirectorsTalk Interviews
Nyxoah receives Medicare reimbursement increases for Genio - MSN
Nyxoah to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
PRN_FinancialWrapper | PR NewswireNyxoah to Present at the 44th Annual J.P. Morgan Healthcare Conference - FinancialContent
Contrasting Azenta (NASDAQ:AZTA) and Nyxoah (NASDAQ:NYXH) - Defense World
Baird Maintains Nyxoah SA(NYXH.US) With Hold Rating, Cuts Target Price to $5.87 - 富途牛牛
Nyxoah to Participate in Upcoming Investor Conferences - Macau Business
Nyxoah SA (NYXH) Stock Analysis: Exploring a 145.53% Potential Upside in the Medical Tech Sector - DirectorsTalk Interviews
0.53%
1.58%
자본화:
|
볼륨(24시간):